NewslettersEndothelial Cell NewsPulmonary Cell NewsUmbilical & Placental Cell News NMPA Accepts Bio-Thera Solutions’ Biologics License Application (BLA) for BAT1706, A Proposed Biosimilar to Avastin® By Justin.choi - June 22, 2020 0 Bio-Thera Solutions announced that the China National Medical Products Administration (NMPA) has accepted the Biologics License Application for BAT1706, a proposed biosimilar to Avastin®. [Bio-Thera Solutions (Business Wire, Inc.)] Press Release